4//SEC Filing
LOPEZ DAVID L 4
Accession 0000946486-10-000033
CIK 0000946486other
Filed
Sep 28, 8:00 PM ET
Accepted
Sep 29, 9:00 AM ET
Size
6.3 KB
Accession
0000946486-10-000033
Insider Transaction Report
Form 4
LOPEZ DAVID L
Executive VP & Legal Counsel
Transactions
- Award
Common Stock
2010-09-27+225,000→ 278,834 total
Holdings
- 38,385(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]New Restricted Stock Award Shall fully vest upon the earlier of (i) the second anniversary of the date of grant (ii) approval of Discovery Labs New Drug Application for Surfaxin (R) for the prevention of RDS or (iii) the effective date of a strategic alliance, collaboration agreement or other similar arrangement between Discovery Labs and one of more third parties providing for the support for the development and/or commercialization of one or more of Discovery Lab's lead research and development programs - Surfaxin (R), Surfaxin (TM), and Aerosurf (R).
- [F2]Transaction reported on Table I represents Issuer's matching stock contribution pursuant to 401(k) plan.
Documents
Issuer
DISCOVERY LABORATORIES INC /DE/
CIK 0000946486
Entity typeother
Related Parties
1- filerCIK 0001283889
Filing Metadata
- Form type
- 4
- Filed
- Sep 28, 8:00 PM ET
- Accepted
- Sep 29, 9:00 AM ET
- Size
- 6.3 KB